Skip to content

Microvascular Complications in Patients with Type 1 Diabetes

Microvascular complications in patients with Type 1 Diabetes. To determine the relationship between abnormalities of autonomic function and markers of microvascular disease and cardiovascular risk in patients with Type 1 Diabetes.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12605000739617
Enrollment
50
Registered
2005-11-11
Start date
2004-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Type 1 diabetes is associated with the development of microvascular complications including nephropathy, retinopathy, peripheral and autonomic neuropathies. Diabetic autonomic neuropathy is a serious yet under-recognised complication. It is thought that the presence of autonomic neuropathy heralds more widespread implications both in terms of cardiovascular risk and its close relationship to other microvascular complications. This study hopes to determine the relationship between autonomic neuro

Type 1 diabetes is associated with the development of microvascular complications including nephropathy, retinopathy, peripheral and autonomic neuropathies. Diabetic autonomic neuropathy is a serious yet under-recognised complication. It is thought that the presence of autonomic neuropathy heralds more widespread implications both in terms of cardiovascular risk and its close relationship to other microvascular complications. This study hopes to determine the relationship between autonomic neuropathy, markers of microvascular disease and cardiovascular risk. This cross-sectional analysis of the study population at a single site will consist of an initial visit when the patient will present to the clinic in a fasting state. At this visit the patient will have the following procedures: 1. Two measures of autonomic function (pupilometry and R-R variability). 2. Pulse wave analysis 3. HbA1c, EUC, B-type natriuretic peptide (BNP) and lipid levels 4. Retinal photography 5. Neurothesiometry 6. Electronic Blood pressure 7. Fitting of a 24 hour ambulatory blood pressure monitor 8. A timed overnight urine measurement of Albumin Excretion Rate 9. A 24 hour urine collection to measure Creatinine Clearance 10. Ankle Brachial Index measurement The patient will be asked to return in 12 months time and have a repeat of all the procedures.

Sponsors

Sydney Diabetes Clinical Research Unit, Royal North Shore Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who have been informed of the study procedure and have given written informed consent.2. Unequivocal diagnosis of Type 1 diabetes mellitus.

Exclusion criteria

1. Patients who are unwilling or unable to attend the clinic on two consecutive days.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026